Cargando…

Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?

Detalles Bibliográficos
Autores principales:	Mannucci, Edoardo, Dicembrini, Ilaria, Lauria, Angelo, Pozzilli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	The Heart in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920786/ https://www.ncbi.nlm.nih.gov/pubmed/23882055 http://dx.doi.org/10.2337/dcS13-2018

Ejemplares similares

The Case for: Hypoglycemia Is of Cardiovascular Importance
por: Lalic, Nebojsa M.
Publicado: (2013)

Cardiovascular Importance of Hyperglycemia and Hypoglycemia
por: Tkáč, Ivan
Publicado: (2013)

Cardiovascular effects of basal insulins
por: Mannucci, Edoardo, et al.
Publicado: (2015)

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations
por: Hirshberg, Boaz, et al.
Publicado: (2013)

Glucose Control and Cardiovascular Disease: Is it important? No
por: Conget, Ignacio, et al.
Publicado: (2009)

Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies
por: Silverii, Giovanni Antonio, et al.
Publicado: (2021)

Correction to: Glucose control in diabetes during home confinement for the first pandemic wave of COVID‑19: a meta‑analysis of observational studies
por: Silverii, Giovanni Antonio, et al.
Publicado: (2021)

Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project
por: Dicembrini, Ilaria, et al.
Publicado: (2021)

Cigarette Smoking as a Predictor of Sodium–Glucose Cotransporter 2 Inhibitor–Associated Genital Infections: A Retrospective Cohort Study
por: Scoccimarro, Daniele, et al.
Publicado: (2021)

Obesity, Autoimmunity, and Double Diabetes in Youth
por: Pozzilli, Paolo, et al.
Publicado: (2011)

Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support
por: Scoccimarro, Daniele, et al.
Publicado: (2021)

Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
por: Pala, Laura, et al.
Publicado: (2012)

Glycemic Variability: Both Sides of the Story
por: Ceriello, Antonio, et al.
Publicado: (2013)

Bone: Incretin Hormones Perceiver or Receiver?
por: Dicembrini, Ilaria, et al.
Publicado: (2012)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
por: Monami, Matteo, et al.
Publicado: (2011)

Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
por: Uccellatore, Annachiara, et al.
Publicado: (2015)

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
por: Iguchi, Moritake, et al.
Publicado: (2023)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Thakkar, Aarti, et al.
Publicado: (2021)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Martínez, Felipe
Publicado: (2021)

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
por: Monami, Matteo, et al.
Publicado: (2012)

Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus
por: Bigagli, Elisabetta, et al.
Publicado: (2020)

The Cardiovascular Benefits Associated with the Use of Sodium-Glucose Cotransporter 2 Inhibitors – Real-World Data
por: Gallwitz, Baptist
Publicado: (2018)

The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use
por: Price, David, et al.
Publicado: (2016)

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
por: Buzzetti, Raffaella, et al.
Publicado: (2020)

Assessment and management of cardiovascular disease in the intensive care unit
por: Cook, David Jonathan, et al.
Publicado: (2022)

Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice
por: Agca, Rabia, et al.
Publicado: (2022)

Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons
por: Hermanides, Jeroen, et al.
Publicado: (2011)

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

Imaging as a surrogate marker of drug efficacy in cardiovascular disease
por: Tarkin, Jason M, et al.
Publicado: (2019)

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors
por: Neumiller, Joshua J, et al.
Publicado: (2022)

Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease – Implications for Clinical Practice
por: Fitchett, David H
Publicado: (2018)

Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)
por: Dicembrini, Ilaria, et al.
Publicado: (2022)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
por: Budoff, Matthew J., et al.
Publicado: (2017)

Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
por: Galati, Giuseppe, et al.
Publicado: (2021)

Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies
por: Silverii, Giovanni Antonio, et al.
Publicado: (2023)

Optimal diet for cardiovascular and planetary health
por: Verschuren, W M Monique, et al.
Publicado: (2022)

Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
por: Dandona, Paresh, et al.
Publicado: (2017)

Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
por: Heinemann, Lutz, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vunin4plt7unse096rtnh6lv87